Article Information
History
- May 5, 2020.
Article Versions
- Version 1 (February 13, 2020 - 09:54).
- Version 2 (April 9, 2020 - 05:42).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tracy J. Berg1,
- Carolina Marques2,
- Vasiliki Pantazopoulou1,
- Elinn Johansson1,
- Kristoffer von Stedingk3,4,
- David Lindgren1,
- Elin J. Pietras5,
- Tobias Bergström6,
- Fredrik J. Swartling6,
- Valeria Governa7,
- Johan Bengzon8,
- Mattias Belting6,7,
- Håkan Axelson1,
- Massimo Squatrito2 and
- Alexander Pietras*,1
- 1Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden
- 2Seve Ballesteros Foundation Brain Tumor group, CNIO, Madrid, Spain
- 3Department of Pediatrics, Clinical Sciences Lund, Lund University, Lund, Sweden
- 4Department of Oncogenomics, M1-131 Academic Medical Center University of Amsterdam, Amsterdam, Netherlands
- 5Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen 2200, Denmark
- 6Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden
- 7Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden
- 8Division of Neurosurgery, Department of Clinical Sciences, Lund Stem Cell Center, Lund University, Lund, Sweden
- ↵*Corresponding author: Alexander.Pietras{at}med.lu.se, +46709928629